Chang Gong, Zihao Liu, You Zou, Gehao Liang, Yun Ling, Luyuan Tan, Yan Wang and Wenjing Zhong
Sun Yat-sen University, China
Cardiff University, UK
Posters & Accepted Abstracts: J Cancer Sci Ther
Increasing evidence suggests circRNAs exert vital functions in tumor progression via sponging miRNAs. However, the role of circular RNAs in breast cancer remains mostly unclear. Here, we reported the molecular mechanisms of a novel circRNA, hsa_ circ_001783 in regulating breast cancer progression and its ability in predicting clinical outcomes by integrating high throughput computation, experimental technologies in vitro and clinical investigation. Our computational pipeline identified hsa_circ_001783 as the one with highest score out of 594 breast cancer-associated circRNA candidates. We found the circRNA was enriched in cytoplasm and overexpressed in breast tumor as compared to paired non-cancerous tissue. High expression of hsa_circ_001783 correlated with higher tumor burden (p=0.047) and poor overall survival (p=0.025) in 128 patients. Knock-down of hsa_circ_001783 remarkably inhibited the proliferation and invasion of MDA-MB-231 and MDA-MB-468 cells. We found hsa_circ_001783 increased significantly by 1.5-2 folds while 7 miRNAs, predicted targets of hsa_circ_001783, were remarkably reduced (fold change>1.5) in mRNA expression levels in BT549, MDA-MB-468 and MDA-MB-231 as compared with MCF-7 breast cancer cell lines. Among all the targets, miR-200c was the one in the strongest correlation with hsa_circ_001783 in expression levels. Knockdown of hsa_ circ_00178 in MDA-MB-231 breast cancer cells suppressed expression of miR-200c-targeted genes ZEB1, ZEB2 and CCNA2. The expression level of hsa_circ_001783 in human breast cancer tissues negatively correlated with expression of miR-200c (p=0.0286) but positively correlated with that of ZEB1 (p=0.002), ZEB2 (p=0.0001) and CCNA2 (p=0.005). In conclusion, hsa_circ_001783 regulates breast cancer progression via sponging miR-200c. The circRNA may serve as a novel predictor of clinical outcomes for breast cancer.
Cancer Science & Therapy received 5332 citations as per Google Scholar report